Document is current
Any future updates will be listed below
-
Authors
Bhamra, Manvir
Harbottle, Zoe
Golding, Michael A
Ben-Shoshan, Moshe
Gerdts, Jennifer D
Protudjer, Jennifer LP https://orcid.org/0000-0002-3888-8688
-
Funding
Funding for this research was provided by:
Canadian Allergy Asthma and Immunology Foundation (Top 10 Challenge)
- License Information
-
More Information
Article History
Received: 6 February 2023
Accepted: 6 June 2023
First Online: 8 July 2023
Declaration
:
: This study was approved by the University of Manitoba Health Research Ethics Board HS25168 (H2021:340).
: All authors have read and approved the submitted version of the manuscript.
: ZH declares no real or perceived conflicts of interest.MB declares no real or perceived conflicts of interest.MG declares no real or perceived conflicts of interest.MB-S is part of the advisory Board or equivalent: Bausch, Stallergenes, Novartis, Sanofi.Payment (including gifts or in-kind compensation) from a commercial organization: Bausch, Stallergenes, Novartis, Sanofi, Stallergene. Participating or participated in a clinical trial: Novartis, Aimmune, Sanofi.JG is the Executive Director of Food Allergy Canada, and is the co-lead of Canada’s National Food Allergy Action Plan.JP is Section Head of Allied Health, and, Member of the Board, Canadian Society of Allergy and Clinical Immunology, and is on the steering committee for Canada’s National Food Allergy Action Plan. She reports consulting for Novartis, Nutricia and ALK Abelló.
